Search results
Moderna Employees Should Use ChatGPT at Least 20 Times a Day, CEO Says
Gizmodo· 3 days agoStéphane Bancel, Moderna’s chief executive, told the Journal the partnership will be key to...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology By Reuters
Investing.com· 3 days agoGSK said in the lawsuit that Pfizer and BioNTech's Comirnaty vaccines violate the company's patent...
Moderna turns to AI to change how its employees work
BioPharma Dive via Yahoo Finance· 4 days agoThe new agreement allows the biotech’s staff to build their own GPTs for specific purposes. For example, a pilot tool called Dose ID is designed to...
Moderna stock gains on OpenAI deal (NASDAQ:MRNA)
Seeking Alpha· 4 days agoModerna (MRNA) stock gains as company announces a deal with AI company OpenAI to accelerate the development of new medicines. Read more here.
Moderna Options Trading: A Deep Dive into Market Sentiment - Moderna (NASDAQ:MRNA)
Benzinga· 6 days agoModerna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with ...
Cancer jab offers hope of a cure as NHS trials vaccines that 'destroy melanoma'
The US Sun· 2 days agoTHE world's first personalised mRNA cancer jab for melanoma is being tested in British patients. The...
J.W. Cole Advisors Inc. Purchases 174 Shares of Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 2 days agoJ.W. Cole Advisors Inc. lifted its stake in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 8.5% during the fourth quarter, according to the company in its most recent 13F filing ...
Moderna To Present Respiratory & Cytomegalovirus Research at the ESCMID Global Congress
Digital Journal· 3 days agoBy working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest ...
Man receives world’s first melanoma vaccine — trial underway
NY Post via Yahoo News· 1 day agoThe Phase 3 trial hopes to recruit 1,100 people. The vaccine, called mRNA-4157 (V940) works...
British patients test world’s first personalised mRNA jab for melanoma
Press Association News via AOL· 2 days agoA stage 2 trial of the jab, involving pharma firms Moderna and MSD, found it dramatically reduced...